An observational study in Myocardial Infarction (MI) and Acute Cardiovascular Disease, sponsored by State Institution "Republican Scientific and Practical Center" Cardiology, Belarus. Active, not recruiting at 1 site in Belarus. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-10.
Sponsored by State Institution "Republican Scientific and Practical Center" Cardiology, Belarus · Observational
This is a retrospective observational study using the methodology of creating medical registries. The expected number of patients included in the registry is about 2000 patients with myocardial infarction and/or ACVD of any duration and concomitant non-cardiac diseases of therapeutic profile in pilot healthcare organizations for any reason during 2019-2022 based on the source medical records data.
The implementation of the task results will improve the efficiency of secondary and tertiary prevention of diseases of the circulatory system - pathology that makes the greatest contribution to the main medical-demographic and socio-economic losses of the state by determining the number of groups with the highest risk of death in outpatient and polyclinic institutions among patients after myocardial infarction, ACVD, living in the Republic of Belarus, to create programs of additional measures to reduce morbidity and mortality of the population based on a comparison of register data and official statistical forms, which will ultimately affect the reduction in the incidence of non-fatal recurrent cardiovascular events in individuals after AMI, ACVD and / or their combination of any duration in the range of 0.2-1% of the indicators determined during the study.
2,270 studies on the registry are indexed under Myocardial Infarction; 371 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 568 across 814 observational studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →State Institution "Republican Scientific and Practical Center" Cardiology, Belarus is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients who applied to the pilot ambulatory health care organizations between 2019-2022 in order to identify and "look for" patients after acute cardiovascular event, but who were not monitored for that event for various reasons (statute of limitations, refusal, relocation, etc.); meeting the inclusion criteria and not meeting the exclusion criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Some patients with non-fatal myocardial infarction
Hospitalization due to cardiovascular diseases, some patients with hospitalization due to cardiovascular diseases
Mortality from other causes
number of deaths from other diseases
Time frame: 3 years
Time to combined end point
non-fatal myocardial infarction or non-fatal cerebral stroke or coronary/carotid revascularization
Time frame: 3 years
Proportion of patients with non-fatal myocardial infarction
non-fatal myocardial infarction
Time frame: 3 years
Proportion of patients with non-fatal cerebral stroke
non-fatal cerebral stroke
Time frame: 3 years
Proportion of patients with COVID-19 cases during follow-up
COVID-19 cases during follow-up
Time frame: 3 years
Hospitalization due to cardiovascular diseases
Proportion of patients with hospitalization due to cardiovascular diseases
Time frame: 3 years
COVID-19-related hospitalization
Pproportion of patients with COVID-19-related hospitalization
Time frame: 3 years
Plan to share: Undecided — Protection of personal data
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
State Institution "Republican Scientific and Practical Center" Cardiology, Belarus